Recipharm

Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, development and technology services. The company’s manufacturing services include contract manufacturing of pharmaceuticals such as semi-solids, oral liquids, solid doses, and sterile products, besides clinical trial materials including APIs and other drugs. Recipharm’s development and technology services assist customers from the initial product concept to the approved commercial pharmaceutical drug.

CDMO Services:
Analytical Services, API Biologics (Cell, Gene, Vaccine and Virus), API Biologics (Protein and Peptide), API Chemical, Clinical Dose, Clinical Packaging, Commercial Dose- Injectables, Commercial Dose- Non Sterile, Commercial Dose- Other, Commercial Dose- Solid Dose, Commercial Packaging.

Year Founded: 1995

Head Office: Stockholm, Sweden

Number of Facilities: 31

Facility locations: France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US

Website: Visit Recipharm website

Linkedin: Connect on Linkedin